SPONSORS

BIOORTHOGONAL CATALYSIS - PRODRUG THERAPY

 

  • H2020 (MSCA-ITN THERACAT)

  • MRC Confidence in Concept

  • EPSRC (Healthcare Technology Challenge Award & Research Grant)

  • H2020 (MSCA-IF 2014, 2017 and 2018)

  • Cancer Research UK (Pioneer Award)

  • Royal Society (Research Grant)

  • Cancer Research Technology

  • SULSA & Merck Sharp Dohme (Postdoctoral Award)

  • College of Medicine & Veterinary Medicine (Principal's Scholarship)

  • Alfonso Martin Escudero Foundation (Postdoctoral Award)

  • Edinburgh Cancer Research Centre (Development Fund)

  • Institute of Genetics & Molecular Medicine (HWU-IGMM Pilot Project & Lab Start-up Package)

  • College of Medicine & Veterinary Medicine (Darwin's Scholarship)

 

 

COOPERATIVE LIGAND-BASED DRUG DESIGN & PHENOTYPIC SCREENING

 

  • Horizon 2020 (H2020-MSCA-IF-2016)

  • Medical Research Scotland & IOmet Pharma Limited (PhD Studentship Award)

  • Breast Cancer Now (Catalyst Award)

  • Medical Research Scotland (Undergraduate Vacation Scholarship Awards)

  • College of Medicine & Veterinary Medicine (Principal's Scholarship)

  • Scottish Power (Strategic Alliance Framework Agreement)

  • Edinburgh Bioquarter (Innovation Competition)

  • MRC Technology (IP Support)

  • Welcome Trust (Institutional Strategic Support Fund)

  • Medical Research Council (Doctoral Training Programme & Supplementary Funds)

​

​

​